Top Stories: NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY), VIVUS Inc. (NASDAQ:VVUS), FormFactor Inc. (NASDAQ:FORM), Tesaro, Inc. (NASDAQ:TSRO), Alcoa (NYSE:AA)

NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) announced that it will report second quarter financial results after market close on Thursday, August 13. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) belongs to Healthcare sector. Its weekly performance is -5.00%. On last trading day company shares ended up $0.57. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) distance from 50-day simple moving average (SMA50) is -16.87%.

On 30 July, VIVUS Inc. (NASDAQ:VVUS) reported its financial results for the second quarter ended June 30, 2015 and announced a restructuring plan. Total revenue was $23.0 million in the current quarter, compared to $21.9 million in the second quarter of 2014. Of the total revenue, net product revenue was $14.0 million from sales of Qsymia in the current quarter, compared to $11.0 million in the second quarter of 2014. VIVUS Inc. (NASDAQ:VVUS) shares moved down -9.72% in last trading session and ended the day at $1.30. VVUS Gross Margin is 69.20% and its return on assets is -21.80%. VIVUS Inc. (NASDAQ:VVUS) quarterly performance is -44.92%.

On 29 July, FormFactor Inc. (NASDAQ:FORM) announced its financial results for the second quarter of fiscal 2015 that ended on June 27, 2015. On a GAAP basis, net income for the second quarter of fiscal 2015 was $0.8 million, or $0.01 per fully-diluted share, compared to a net income for the first quarter of fiscal 2015 of $0.8 million, or $0.01 per fully-diluted share, and a net loss for the second quarter of fiscal 2014 of $(4.3) million, or $(0.08) per fully-diluted share. On 04 August, FormFactor Inc. (NASDAQ:FORM) shares advanced 0.57% and was closed at $7.03. FORM EPS growth in last 5 year was 35.90%. FormFactor Inc. (NASDAQ:FORM) year to date (YTD) performance is -18.26%.

On 30 July, Tesaro, Inc. (NASDAQ:TSRO) announced an exclusive license agreement for the development, registration, manufacture, and commercialization of rolapitant in China. Tesaro, Inc. (NASDAQ:TSRO) ended the last trading day at $59.09. Company weekly volatility is calculated as 5.91% and price to cash ratio as 5.92. Tesaro, Inc. (NASDAQ:TSRO) showed a weekly performance of -5.43%.

Alcoa Inc. (NYSE:AA) has earned a “BB+” credit rating from analysts at Morningstar. The firm’s “BB+” rating suggests that the company is an above-average default risk. They also gave their stock a five star rating. Alcoa Inc. (NYSE:AA) ended the last trading day at $9.73. Company weekly volatility is calculated as 3.29% and price to cash ratio as 9.72. Alcoa Inc. (NYSE:AA) showed a weekly performance of -1.42%.

Leave a Reply

Your email address will not be published. Required fields are marked *